Good morning, ladies and gentlemen. Welcome to Grupo Panvel earnings webcast to discuss the results for the third quarter of 2026. This webcast is being recorded, and the replay will be available on the company's investor relations website. The presentation is also available for download. Please note that all participants will be in listen-only mode during the presentation. We will then begin the Q&A session when further instructions will be provided. Interpretation into English and Brazilian Sign Language is available. To enable it, simply click the interpretation button and select your preferred option. Before we proceed, I would like to remind everyone that forward-looking statements are based on Grupo Panvel management's beliefs and assumptions and information currently available to the company. These statements may involve risks and uncertainties as they relate to future events, and therefore depend on circumstances that may or may not occur.
Investors, analysts, and journalists should bear in mind that developments in the macroeconomic environment, the industry, and other factors may cause actual results to differ materially from those expressed in these forward-looking statements. Joining us for this webcast are Mr. Antônio Napp, Chief Financial Officer and Investor Relations Officer, and Mr. Ismael Röhrig, the company's Investor Relations and Strategy Manager. I would now like to turn the floor over to Mr. Antônio Napp, who will begin the presentation. Mr. Napp, please go ahead.
Good morning, good afternoon, or good evening, depending on where you are watching this video from. It is a pleasure to be with you to discuss the results of Panvel's third quarter. Exceptionally today, Julio was unable to join us. He is in China on a mission, and he will come back to help us keep growing so that we have next upcoming quarters that are as good as this one. Thank you. Thank you for your viewership. We have to thank not only the team, but everybody, all the stakeholders that are involved. Julio left me with an easy-to-cover mission.
It is very easy to talk about such good results. Yes, let us do this. We have very complete materials as usual, and we want to share with you what we believe are the main highlights of this quarter. We are going to go into the details of each one of the numbers. The numbers, they speak for themselves, as it were, but this was a very complete and balanced third quarter. The group was able to deliver very robust sales growth accompanied by a growth in result generation and cash generation.
This is easy to say, but it is hard to do. But we have been consistently delivering that over the course of the last quarters. That was aligned with our expectations. It is important to say that. We already had a very positive perspective for each quarter, and it is really fortunate that we were once again able to deliver this. Over the course of the presentation, we will go over the details of what comprises each of these strong results.
Another aspect that we always like to cover, and we never talk only about one quarter, we always like to talk about the consistency across Panvel's results over the course of the years. If you have been with us for some time now, you know that we always talk about these numbers. Panvel has been growing consistently year after year for decades. This is a shorter snapshot, and it is worth looking.
If you look at the last five years, it's worth taking a look at the good job that's been done in value generation for stakeholders. Panvel's been maintaining a growth rhythm of 14.5% over the course of the last five years. This space is being accompanied by an EBITDA growth of almost 17%. It's interesting to see, if you look at the last graph, the EBITDA of the last 12 months, this is a spoiler, if you will, that we've been doing. We've reached a margin of 5.8% in this to-date results. This is a historical level achievement, and it shows how we've been evolving with our deliveries quarter after quarter.
One important thing to say, if you look at the results from 2020 onwards, we've been growing for decades, and when we decided to speed up the growth, I think the graphs and the data, they show very clearly that we delivered everything that we could since 2020, and it's not going to be any different from this cycle onwards. By 2030, we want to double in size. We also like to talk about the CAGR because they can mitigate any other numbers. We are showing that growth has been consistent regardless of what we come across. Yes, exactly. Now we're going to drill into the details of the results of the quarter.
We need to highlight something that's been a differentiator for Panvel for quite some time, and that's now even more important, which is the work that's being done in digitalization, both at the stores and outside of them. Panvel, for a long time now, has been increasing the sales participation through its digital channels, and even more so during the third quarter. We reached a share of almost 47% of retail sales having come from digital channels. How did we achieve that? This work and this expansion was highly focused on an excellent job done with Panvel's app, which accounted for almost 80% of all of the sales in that channel, and also a very well-designed project that started in April inside our stores. We called it a digitalization project, which is represented in the pie chart at the top of the slide.
We've been trying to focus on how we can digitalize more and better the physical stores' customers, transforming the Panvel app into something that's useful at this stage of the journey. By observing the customer's behavior at the stores, and that started back when we started to digitalizing GLP-1, we started to see ways to reduce friction in this customer interaction and to make the use of the app easier, starting with a journey that starts at the app and ends at the sales point in a simple, accessible manner. The customers are able to use a tool that unlocks better conditions, better promotions, and that further increases our capacity to communicate with our customers.
When we start to make these wheels turn at the stores, we can clearly perceive a strong adhesion, and that gives us a huge advantage as a company because the more apps you are able to download, the greater your communicable base is, the greater your capacity to do sales, and the greater the recurrence of your customer. At the end of the day, you increase your NTB. For everything we've done at the stores, we shouldn't forget what we've done outside of the stores. We've been a benchmark for a long time in terms of the capacity to deliver. 33% of our sales are in-home deliveries, and the other 67% are in-store pickups, and this grew more than 20%.
We had almost 900,000 deliveries that were delivered through our own channels, and this capacity to deliver well with the high service level and very fast is also a competitive advantage. This summarizes this perspective that at the end of the day, it's all about how to better serve our customers both in stores and outside of the stores, and also transforming the app into something that they're going to use in these two environments. Yes there is one thing that we always try to deepen, which is a respect for the customer journey. There's no dispute between the channels, the stores and the digital channels. What we see is that the journey is unified. The customer journey is one unique journey, more and more.
If you look at the delivery profile, if it's in-home deliveries or in-store pickup, or in 90 minutes, 30 minutes, or 100 minutes, that's all up to the client to decide. The digital journey is here to improve the customer's journey even more than it was before. So regardless of what they choose, they'll always be able to have a great journey. Yes that has to do with customer loyalty. With this project, we keep on focusing on and expanding our client base. We have 32 million customers on our base, and we activate them. We have them make their first purchase, and the base of active customers doesn't stop growing. In this quarter alone, it grew by 8%. You have to create their loyalty to make them buy more, and that leads to this leap in the number of customers that buy across more than one channel.
We also have our Panvel Prime program, which is a very relevant growth platform for already loyal customers and that have a very high retention rate. Panvel is investing in this customer category. That's something that's visible in our customer services through the digital channels or the physical channels, and we're always going to focus on capital allocation. Investing in this undoubtedly is something that brings about huge returns very quickly. This is our focus, and undoubtedly, if we do this job well done with our customers, was one of the biggest pillars of Panvel's growth, not only during this quarter, but also throughout the entire year of 2026. Another competitive differentiator that's very important is our focus on beauty. Panvel has been, for a long time now, a benchmark when it comes to beauty operations at the stores.
Around 35% of Panvel's sales are related to hygiene and beauty items, and that's been like that for a long time. Since this is such a strategic positioning in beauty, we have another fundamental pillar, which is what we do with Panvel's own brand products. Panvel is again a benchmark for the market, and this share of Panvel's own brand products has been increasing. Aside from GLP-1, this share achieves 8.2% or 7.2% of the entire sales of the group. In terms of hygiene and beauty, where the Panvel own brand products focus more, market share achieves 19%. The Panvel products, in addition to allowing us to penetrate the beauty market more and more, they also allow us to provide access since they are high-quality products with a very good ticket, and they also allow for greater profitability.
This is a very thorough strategy that also connects with customer loyalty. I should also say that by the customers using Panvel brand products more and more, the engagement that that generates on social media is phenomenal. It's not by chance that we are the pharmacy chain with the highest number of followers in Brazil. These are some examples of products, and we have many more to come for our fourth quarter, and they are still a very important pillar. After talking about these differentiators, digital, and the Panvel products, obviously, we start looking at the numbers. Here is where we go into the presentation part where we talk about our DRE. As I said before, many of the numbers speak for themselves. Panvel has been having a very robust growth. We are growing 15.3% in the quarter with no slowing down.
You can see that in the last quarters of the year, we've been maintaining exactly the same pace and the same quality levels. This growth in sales has been accompanied by a strong growth in the average sales per store. As we all know, the main secret to being able to increase the profitability of your retail business is to increase the average sales per store. The graph on the right-hand side, which shows this data of IQVIA, it demonstrates this growth, and I have to draw your attention to the fact that this growth is much more accelerated than the other players. We've reached in the quarter almost BRL 840,000 of average sales per store. Sales of mature stores, almost BRL 900,000, and the profile of our stores has been significantly improving.
More than half of our stores have been selling above BRL 700,000, and those numbers have been improving quarter after quarter. Yes, another very important piece of information, if you look at the graph in the middle, is that Panvel has been growing, not in at times of GLP-1, it's been growing not only in terms of ticket, but also in terms of customer service volume. We are, in fact, selling more. Not only more expensive products, we're selling more, and we're better positioned across all journeys. We're increasing the number of customers, the number of customer interactions, and we've been having a very healthy balance for quite some time now between ticket and sales volume. Yes, exactly. That takes us back to the sales of mature stores. That is the basis of the company.
We have to keep on opening good stores so that they become excellent mature stores, and this is something we've been doing. You can see that both indicators are very strong, and they won't slow down over the course of the year. We grew 13.12% and 11.5% in mature stores. These are much superior indicators than the growth of inflation in the same period, and they're guaranteeing great gains in productivity. I should also say that this growth, this is another very important characteristic of Panvel's. This growth in sales is very balanced out. This graph, I really like it because it conveys a message of balance, which shows that in spite of GLP-1, and we're going to talk more about that, even though GLP-1 is very important for Panvel, and it's also a great growth driver, Panvel's also been growing outside of GLP-1.
We take every opportunity to capture clients, to increase their basket, and to be able to offer more products. You see that there's been a huge growth in our generics category, 19%, almost the same as the own brand growth, and also a strong growth in hygiene and beauty. What's interesting is that this pattern of growth does not apply only to the third quarter. We like to talk about the figures, as you said in the beginning of our presentation, because they show consistency. You can see that over the course of these last five years, this is the behavior change that we've been seeing, a good growth in GLP, hygiene and beauty, and own brand products. Working that way means that we're serving our customers across all of their needs and also guaranteeing a very balanced out gross margin.
Yes, and this reinforces what we've seen in the digital channel. We've seen the sales composition in the mix, and indeed, Panvel, we can definitely say that Panvel is the best prepared pharmacy that's better able to receive all sales journeys, regardless of whether it is in the digital channel, basket of generics, or health and beauty products. We have the most complete journey, the one that's most adaptable to the customer's needs. Yes, exactly. This is what the market share data show. This is the 26th consecutive quarter in terms of market share gains. We gained a lot of share in all of the southern states, in São Paulo capital city, and also market share in all of product categories. So it is a very thorough growth.
This graph at the top, which is also taken from IQVIA, it's an external agent translating our internal data that we are now publishing. You can see that Panvel grows almost twice as much as the rest of the market, both in terms of volume and average price, in a way that's much better than the other chains, whether they are small, medium-sized, or large-sized. This growth, if you look at our last quarters, it's been constant. It's one of our concerns. Growing with quality means that we're growing by increasing the number of customers and having them buy more, and obviously improving their basket of products. Panvel has been able to achieve these goals over the course of this period. All of that sounds really pretty. Numbers are great, but that happens because we provide great customer service at the stores.
There's no use growing fast and seeing a significant worsening of the customer interaction indexes. This is not what happened at Panvel with our NPS numbers show that. We've been following our growth acceleration by increasing our NPS that has been following the same trends. If you look at our physical stores, our app, our site, all of that fills us with pride, and this is everybody's goal. Each coordinator, store manager, and every leader has an NPS in their goals because there's no way we can grow in the pharmaceutical industry if we're not obsessed with consumers. Yes, we had a growth of four points in the app NPS, more than 270% of growth in this channel. Being able to expand our NPS like that is truly a strong message, right? Correct. Now we are moving away from the world of sales.
Now we're going into the world of gross margin. The gross margin in retail saw a slight decrease, zero point two points, which is totally healthy and expected. This strong growth in the medications category and an increase in digitalization naturally focuses more on the gross margin, which is offset by the expenses, which is good, is that we have a good toolbox that helps us mitigate these negative impacts, whether it is the value of our brand, negotiation with the industry, which the commercial team always focuses on, a great work in pricing. There's no way for you to be competitive in retail without having a whole team dedicated to pricing. Obviously, as I said, we're growing well in generics, own brand, and hygiene and beauty are also factors that help us balance out the margin. We have the perspective of maintaining a healthy margin.
Of course, seasonal pressures may occur, but the margin's going to remain healthy, even over the course of the next quarters, even coming from categories with a slightly lower margin. We increased our average sales, we controlled our costs very well, and we're now in another strong quarter of diluting the expenses. We diluted the expenses with sales by 0.7 percentage points. Also, our administrative expenses are super balanced, and our future perspectives remain like that. We have every tool at our disposal to keep growing healthily by controlling costs and to open up more opportunities to increase our margins, as we've been doing for the third quarter. Obviously, that takes us back to the EBITDA and the profit. We like to start with the EBITDA four-Wall, which is the representation of the specific results of the stores. Some companies call it a contribution margin.
It's the same thing, except for the depreciation. This makes it clear how our performance of our stores has been increasing, even though we're expanding and opening stores. We opened 14 new stores this quarter, but still, our margins are still going up. We increased or we grew by more than 20% our EBITDA four-Wall, quarter versus quarter, a growth of zero point three points. We're doing that in a way that's also extremely balanced, and I like this word, balance. I think it represents us well, in a balanced way across states. If you look at this slide, we always talk about the quarter. We can go into the details of our return of our stores in general and the results by state.
After each quarter, we've been able to improve the performance of our stores in the states where we have a faster expansion, such as Paraná, Santa Catarina, and São Paulo. Rio Grande do Sul is a great strength in terms of margin. This is what we keep focusing on. We are leading through our mature stores, and even the stores of our states are at the same levels of Rio Grande do Sul. We have to capture results. If you look at the average age of the stores in São Paulo, Santa Catarina, they're much younger than Rio Grande do Sul. In this maturing process, we're closing the gap more and more between the states and Rio Grande do Sul. Of course, that has to connect us back to the EBITDA of the group. This is no different.
We grew our EBITDA in this quarter by more than 21%, expanding our margin by zero point three points. If you look at the year-to-date CAGR over the nine-month period, we've been growing at almost 17% per year. It's a compound growth that's quite robust, and it's been speeding up over the course of the last years. This makes us confident in our capacity to execute the plan, and this leads us to this strong growth in the net profit, which grew by more than 35% in the last quarter, which fills us with pride. It's very representative of our operational efforts of the company. Our net margin is 2.7%, and it's very important for us, the net margin. It's a margin that we reached in the fourth quarter, which is usually the greatest potential quarter.
We can only imagine what's expecting us for the fourth quarter of 2026, and that's consistent across all of the lines. We had very healthy sales. We were able to work very well with the raw margins, the gross margins, and we reduced the expenses. This shows in our results, and it couldn't be any different with our cash flow. There's no use having a healthy P&L if your cash flow does not respond adequately. We're now entering the seventh consecutive quarter of generation of free cash flow, almost BRL 20 million, BRL 65 million in operating cash flow. We once again reduced our leveraging. Our net debt is still decreasing.
It reached 0.8x , and having a balance of this quality with a low debt as the one that we have and still keeping on growing and generating cash flow is a competitive differentiator, especially in a scenario of high interest rates, as is the case, many competitors being indebted. Having this financial leeway guarantees that even though this scenario is not that benign, that we can keep on investing, and all of that without stopping the opening of new stores, right? Generating this free cash flow in a quarter where we've opened the most stores is in fact the result that cannot be denied or translated as an optimized operation that focuses on productivity. Exactly. Now, we're reaching the end of our presentation. We always like to give you an idea of what is to come and to share our strategic pillars.
I think you all know this slide. We like to talk about it because it's in fact our plan. We have a long-term perspective. We're growing. We've entered the first year of this five-year plan, delivering everything that we committed to. We're very confident. As I said, regardless of the scenario that we're facing, be it due to the strengths of the pharmaceutical retail industry, and I should repeat this, the pharmaceutical retail is undoubtedly one of the best markets to operate in Brazil. It's a market that, structurally speaking, will keep on being extremely strong, be it due to the release of new products or to the population aging. Anyway, it's a very healthy market. Panvel has been operating very consistently with a focus on consolidation, as we can see in the market, that opens up many other opportunities.
This is yet another pillar that makes us very confident to move forward. This hasn't changed at all, if you look at the big picture. If you go into the details, this is obviously the most interesting slide for everybody, and I'm sure that people are going to ask questions about this. We follow the strong trend of GLP-1. It's not a trend, it's a reality, but it keeps its position as an important growth pillar for the future. We also had the opportunity to test the hypothesis of elasticity very strongly in the third quarter. Clearly, as we saw the average price of products going down, especially that of semaglutide, we saw that the number of sales went up, and that brought more customers into the store, and we had the opportunity to also be able to sell other items in an extremely positive movement.
We do believe that this cycle will keep on happening. More products are to come, and we tend to have to face more pressure for price. As competition grows, we also believe that we're going to have more opportunities to improve the gross margin of these products, balancing out the entire growth. Also, the cash cycle, because by seeing that, we're going to see better conditions in terms of payment terms. The vendors are going to be positively impacted as this category is growing and consolidating. As he said, it's a constantly evolving category. Every month, there is a new similar product. Quite recently, we saw the approval of the same medication in tabs for people that are scared to take injections.
This is becoming more and more consolidating, which allows the pharmacy to have this even greater relevance in negotiations, be they related to payment terms, gross margin, and all that. It's a very promising future for this category, which is really only just beginning. Exactly. I think that Panvel stands out in these sales. In GLP-1, we have a market share of almost 30%, so Panvel is better than the average. That brings about the benefits from this category, which is growing so strongly. Now looking into the future, the perspectives haven't changed a bit. It's worth mentioning, and this is an important message, the fourth quarter always has a very high basis of comparison because it's extremely disproportional vis-a-vis the other quarters. October is gone.
We are now in the beginning of November, and Panvel, every year, it stands out in these periods of holidays, as is the case of Black Friday and Christmas. These are some of the numbers that are available, just so you have an idea of how the company grows in the fourth quarter vis-a-vis the third. That has always been the case, unlocking more sales, more productivity, more value as well. That leads us to this very positive perspective. We are very well prepared now. We are starting this with the right foot for the end of the year, and all of the perspectives, we believe that they are going to be delivered. We will have a strong year ahead in terms of growth in sales, in results, and also return, which is very important. Our return measured by the ROIC has been growing quarter- after- quarter.
After all that, we are very happy about our journey so far, but this couldn't be done if it were not for the people. I want to wrap up the presentation now before we start the Q&A session by first thanking our entire team, the team that is working in the fields at the stores, the logistics teams at the offices. They make a huge difference. I also want to draw your attention that in the third quarter, we had the opportunity to revisit some of our values and our raison d'etre and our mission. We reinforced all of our communications about that with our internal teams. There is also a very important aspect related to that. In terms of our reason for existing, it really translates our work, what we have been doing. We are people taking care of people.
That establishes a connection with our customers, with our collaborators. This creates a virtuous cycle of high-quality customer service and a concern around doing things increasingly better. This slide translates very well how we act and how we think. I want to leave you with it on the screen before we start the Q&A session and reinforce my thanks for everybody that has joined us so far, the stakeholders, and everybody that is watching us. Now we are available to take questions. We will try to answer them as best as we can, me and Ismael.
Thank you. We will now begin the question and answer session for investors and analysts. If you would like to ask a question, please click Raise Hand. If your question has already been answered, you may leave the queue by clicking Lower Hand. The first question comes from Ms. Laryssa Sumer from XP. Ms. Laryssa, you have the floor.
Good morning, everybody. Ismael, Napp, congratulations on the surprising results. I have two questions. The first one about the expenses with sales. You reported a good dilution in the third quarter, and apparently, we will keep seeing this dilution. For 2027, I would like to understand if anything will change in terms of your plans, in terms of the new work schedule, and how this is going to behave next year, and the mitigation measures, if any. You also talk about the digital market in the presentation, but it was also very surprising to see what happened in the quarter. You talked about digitalization and the stores, but maybe you could give us a better idea so that we can better understand what changed about the app to make it so much more attractive. It would be great to understand that. Thank you for taking my question.
Thank you, Laryssa. Thank you. Okay, let's start with the expenses with sales. We maintain our positive perspective for the expenses with sales, be they for the fourth quarter or 2027, based on two things. We have the expectation to keep growing healthily the average sales by store, and by reviewing several processes and also automating some of those, we've been managing to increase the average sales without putting pressure on the store workforces. Of course, the rental expenses, they're growing according to the inflation. The other expenses, each one of them have their specific projects that will keep allowing us to keep diluting even further over time. Regarding the five on, two off work schedule, all of our stores are operating on that schedule.
According to our study, the first phase of 42 hours has very little impact in terms of us having to hire more people. We might need to make a few adjustments in terms of the opening hours, but according to what we've analyzed during the first phase, the impact is going to be lower. After the change to the 40-hour work schedule, weekly schedule for 2028, we will have a greater impact. At the adequate moment, we're going to have to take adequate measures for that by talking about maybe decreasing the opening hours or maybe increasing our prices. But for 2027, we expect to have low impacts. Yes, regardless of the work schedule.
This concern, and we've been discussing with the market for more or less a year now, in terms of focusing heavily on process intelligence and the use of automation and the AI in redesigning the store processes and the direct impacts on the workforces by store, and also the expenses that precede the in-store expenses, that will be maintained. It's our commitment, and that's something that runs in our veins, our focus on operational efficiency, looking at the processes, reviewing them, and using AI and technology more and more to improve our productivity. That's something that's in our hands to improve our efficiency, our processes by using technology. Yes, and to your second question about digital, what changed was that we've always focused on providing a great app experience, whether in the stores or outside of the stores.
When we started to review our customer journey at the stores, and that's why I mentioned GLP-1 in the beginning, the use of the app at the store to close a sale has always had some friction. You had to register your credit card and close your card, sometimes only to try to unblock promotions, benefits, and whatnot. When we reviewed that, we saw that we could have our customers use the app at the stores. If they don't have the app in their phones, they can quickly download them, and they can start their purchase through the app and pay at the cashier at the store. That unlocked the entire process and guaranteed, we wanted to make sure that our collaborators at the store, that they could understand that completely. They finally understood that by talking about the digital app at the stores, that attracts more sales.
We provided them with a sales tool. Our collaborators, they started to offer our customers advantages if they were able to download the app, and with very little friction. When we unblocked all that, we saw that we created a good situation for the company, which started to have a larger communicable base and obviously a greater capacity in sales conversion, and also very good for the client. Yes, and also good for the collaborator. It's not a tool in that it's not a tool that we gave them to create friction, but rather to provide assistance. The greatest differentiator of this project is that we indeed looked at the customer journey, not through channel X or Y. We looked at the journey. How could we unify the entire journey to make everyone's lives easier, the customer, the store, and to improve our experience as a company?
That's super clear. Thank you, and congratulations again.
Thank you, Laryssa.
Our next question comes from Mr. Vinicius Pretto from Itaú BBA. You have the floor, Mr. Vinicius.
Good morning, Napp and Ismael. I want to explore your comments about this new phase of the GLP-1 cycle and the new drugs on the market. Do you forecast any type of improvement to the image and the category and this increase of competition and availability of products in the stores? Is that also improving your conditions with your old vendors? In the last quarter, you said that there was still some provision restrictions for the provision of these similar products. Has that improved now, or is supply still a challenge?
The second thing that I wanted to cover was the slide of the fourth quarter that you covered. The fourth quarter is always strong, but last year, it seemed to have been especially strong. I think Black Friday was very good. GLP-1 was seeing a huge demand. So I'd like to understand your expectations for this year and how challenging you think this base is. Do you think that you're going to be able to maintain this resilient growth that we've been seeing over the course of the last quarters? Thank you.
Thank you. We're going to start answering with GLP-1. Our vision, first, let's talk about the present. We did see some disruptions, especially in terms of the new products. So, we do expect that to become more regular over the course of the fourth quarter, which will become an opportunity. Yes, that's a learning curve of the industry. That's a natural movement.
Yes, that happened in the past with Lilly, with Novo, and it's just natural that the industry will become more and more regular. We have a positive expectation that these disruptions will decrease in the fourth quarter. So this is positive data. Concerning the margins, especially the gross margins, right now, the margins are still a bit locked at around 20%, but we do have very positive expectations for 2027. As the new products start to come to the market, and these conversations have already started, our expectation is that, yes, we will be able to unlock better gross margins due to an increase in competition. There's also one thing.
As we start to see more generics, we will end up having more products competing for the same consumers, and that naturally will require from both vendors and ourselves a better capacity to negotiate and to decide, and that will have a positive impact on the cash flow. Yes, it is an increasingly growing market. We are going to see more and more competitors, and we are going to start testing more and more the elasticity of the product.
It is an ever-growing market with better commercial conditions, so that is very positive. Exactly. Concerning the challenges of the fourth quarter, yes, it is true, the bar is very high for the fourth quarter. The fourth quarter of 2025 had a substantial growth in sales. We set very high growth goals, which we are in line with, and we do believe that we will also have every condition to have a two-digit growth.
We just started at the beginning of the first third of the quarter. We are very excited, but we cannot say that this is strong basis for comparison. Yes, Black Friday is something that is always surprising. We always have a very strong Black Friday that has a huge growth, and the next year we see an even bigger growth and so on and so forth. Yes, it is complex, but it is impressive how the team is able to always do better.
Thank you.
Thank you, Vini.
The next question comes from Mr. Yan Cesquim from BTG Pactual. You have the floor, Mr. Yan.
Good morning, Napp and Ismael. I also have two questions. The first one is somewhat connected to the growth expectations that you have been exploring so well, but maybe from the perspective of competitors and competitive pressure. I would like to understand what you have been seeing, especially in the southern region of Brazil and the regions where you have been opening the most number of stores. How do you see competitors, and what are the main categories that have been leading these share gains that we have been seeing in the region? That is the first question.
The second question is about the expansion of the chain. It was a good question about maintaining the growth perspectives for the fourth quarter, but if you think beyond that, you have a very ambitious goal for 2030, be it from the perspective of expanding the base or the top-line growth, and I would like to understand this component. Maybe some other components also need to be factored in.
How do you see this scenario with higher interest rates in terms of capital allocation for store expansion and maybe other components that will reinforce this positive growth perspective, and maybe in a higher inflation scenario? I would like to understand what you are thinking about that. These are my two questions. Thank you.
Thank you for your questions, Yan. Well, let us start by talking about the competition, the competition in the south of Brazil, and what our perspectives are. For one, the market is still very competitive. I think very few industries have as many competitors as we have in the pharmaceutical retail market. That has not changed. But what we do see is that the economic conditions of Brazil, combined with the indebtedness of several small, mid-sized, and large players, end up having an impact on the growth pace of some of the competitors.
That also generates good growth opportunities for Panvel, which I believe we've been capturing. Will that last forever? Probably not. We've been operating for more than 50 years. We've been through several cycles. The fact that our balance sheet is extremely healthy, with the capacity to invest and keep on opening stores, that undoubtedly is extremely helpful in terms of facing a relevant portion of the competition in the south. Obviously, each competitor has their own strategy, and Panvel has been maintaining its purpose consistency over time by always focusing on health and well-being. In being so consistent, we also simplify the client's choices, and that's also helpful as we sell our brand, if you will. Yes, the differentiator becomes even more important.
At the end of the day, it all comes down to who finances the differentiation, having good inventory and proximity with the customer, and having a scenario where you have two or three drugstores side by side. What attracts customers to your store is having the right price, having the right inventory, and at the right place, at the right time. This intelligence, that cannot be financed otherwise, except for the balance sheet. Yes, we always focus on the digital journey, not only now, but we've been talking about that, and this will not go back. People are going to increasingly more buy online through the app, through their phones, and Panvel's been doing that for quite some time now. So it's just natural that in this transition of habits, that we will also capture more than the average competitor. That will keep on helping us.
That also relates to another part of your question. Our share gains are also balanced across categories, when we try to drill down into because we are always concerned about being too concentrated here or there, but that's not the case. Undoubtedly, we'll keep on getting more and more market share in GLP-1. That's clear. GLP-1 attracts more and more customers to the stores, especially with the drop in prices, which is extremely positive. But you also get a good market share in generics, and hygiene and beauty. This is important data because these are very competitive categories. In the case of hygiene and beauty, it's a category that competes even with other channels in the pharmaceutical retail. So once again, that takes us back to the magic word, balance.
We've been having a balanced growth, placing our bets on good physical stores and the best of digital, and this has been working really well. Now, to your second question about expansion. We've set for ourselves a very strong growth goal. When it comes to physical expansion, our plans have not changed for 2027. We'll probably maintain our growth pace. If you look at our long-term guidance, we're talking about up until 1,000 stores. We're more concerned as a company in reaching the sales results, and obviously of margin and return, and we're a bit less passionate about the number of stores, so to speak. We know that more and more, we're able to reach better sales and more customers without the need to have so many physical stores. The physical stores, will they lose importance? Of course not.
If we're efficient in the digital world, it's because we have a good physical store, well-organized, with a well-trained workforce, with proximity to the customer. That won't change. But probably over time, we might need to achieve the exact same goals or more, maybe with a slightly lower number of stores. If we had a perspective of decreasing interest rates, we might take the decision to speed up our pace. But for now, we've decided to maintain our pace. Yes, we showed the slides of our plan for this period all the way to 2030. That won't change because we are increasingly more able to extract the same productivity from the exact same stores. If you look at the mature stores, they're growing by two to three times inflation. That's the verification that we're able to grow and generate productivity without endlessly increasing the number of stores.
We're able to extract more and more. Almost 20% of our stores still have to mature. So, in addition to maintaining the expansion, we are still obsessed by extracting increasing productivity from mature stores. Your question was about the other components. Well, we have several. We have our own brand, digitalization. Actually, our own brand in this beauty market, we're extracting increasingly higher value from it. We have the entire chain ahead of that, and there's also other components that also relate to that, and that don't make us hostages to having to endlessly increase the number of stores. We're able to better serve more and more customers without necessarily having to exponentially growing our store network.
Thank you. That was great.
Thank you, Yan.
This concludes our question and answer session. We would like now to turn the floor back to Mr. Antônio Napp for the company's closing remarks.
Well, once again, I want to thank you for your viewership. I also want to thank my colleague, Ismael, who supported us for this call. We're very happy to be delivering such great results, but we have a lot of work to do ahead of us. I want also to highlight my special thanks to our collaborators. I know that there's a huge team watching this, and they all root for us. I wish you all a great end of the year, and may we all be successful. Thank you. Thank you for your viewership and the other questions. Any further questions, the investor relations team is always available. We're here to help you. So once again, thank you for your viewership, and hopefully we're going to be able to see each other again with very good news again for the fourth quarter.
This concludes Grupo Panvel's earnings webcast. Thank you all for joining us, and have a great morning.